#ASH20: David Alt­shuler and the Ver­tex/CRISPR team hit a his­toric mile­stone in the hunt for a cu­ra­tive gene edit­ing ap­proach to sick­le cell dis­ease, be­ta tha­lassemia

Back in the mid-80s, David Alt­shuler worked in Richard Mul­li­gan’s fa­mous Har­vard lab, fo­cused on he­mo­glo­binopathies and the glim­mer­ing promise of a gene ther­a­py for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER